北海康成-B(01228)附属拟委任百洋医药附属公司为独家合同销售组织以推广集团的若干产品

Core Viewpoint - Beihai Kangcheng-B (01228) has announced a strategic partnership with a subsidiary of Qingdao Baiyang Pharmaceutical Co., Ltd. (301015.SZ) to promote certain products in mainland China, Hong Kong, and Macau through an exclusive commercial service agreement [1] Group 1 - The agreement establishes Baiyang's subsidiary as the exclusive Contract Sales Organization (CSO) for promoting the group's products in the specified regions [1] - The promotion is subject to the upstream authorization agreements established by the group's member companies and the respective product authorization [1] - Baiyang's affiliated companies may act as distributors for the products in the relevant regions at Baiyang's discretion [1]